The crisis we are living through, though unprecedented, will pass. The degree to which life returns to some form of normality is, however, an open question and will largely be determined by if, and when, a vaccine is developed so that normal daily activities can safely resume.The one thing the past few months has taught us is that it was easier to go into lockdown than it will be to emerge from it.The exact path the infection will take is still uncertain and there is a risk that despite best efforts, finding a vaccine or more effective treatment may remain a challenge for some time. If this is the case, the economy will need to adapt to living alongside the virus, which will obviously have dire consequences for many businesses and will test the ability of management teams to adapt.If a vaccine is, however, made widely available in the next 12 to 18 months, a degree of normality would likely rapidly return. As equity investors are forward-looking creatures, it’s worth spending some t...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now